Phase
Condition
Retinoblastoma
Neuroblastoma
Treatment
EMLA Cream
Num Vapocoolant Spray
Clinical Study ID
Ages 4-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
English-speaking
Present appointment is for drawing blood, receiving intravenous antibiotics, bloodproducts, or chemotherapy
EMLA cream has (standard of care) or has not (vapocoolant) been applied to the portsite prior to the appointment
Previous allergic reaction or skin irritation due to EMLA
Quick access to the child's port is needed for drawing blood, or giving treatments,blood products, or drugs such as chemotherapy
Exclusion
Exclusion Criteria:
Child has a legal guardian or non-parent family member as the only adult with themfor the visit.
Children less than 4 years of age
Children with altered mental status
History of traumatic brain injury, developmental delay or autism
Child is nonverbal
Present appointment is for drawing blood, receiving intravenous antibiotics, bloodproducts, or chemotherapy, and child and parents prefer to wait for EMLA cream totake effect.
Study Design
Connect with a study center
University of Kentucky DanceBlue Pediatric Hematology/oncology clinic
Lexington, Kentucky 40506
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.